// App-Quantinova.ai

THU0082 : MEDICATION IMPACT ON THE RISK OF INCIDENT DIABETES MELLITUS IN PATIENTS WITH RHEUMATOID ARTHRITIS: HYDROXYCHLOROQUINE AND ABATACEPT PROTECT WHILE GLUCOCORTICOIDS AND STATINS WORSEN

Researchers

Presenter

  • G. Ozen

Principal Investigators

  • S. Pedro

  • M. Holmqvist

  • K. Michaud

Medical Centers

  • University of Nebraska Medical Center, Omaha, NE, United States

  • Marmara University School of Medicine, Istanbul, Turkey

  • National Data Bank for Rheumatic Diseases, Wichita, KS

  • Karolinska Institutet, Stockholm, Sweden

Locations

  • United States

  • Turkey

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Rheumatoid arthritis

  • Diabetes

  • Coronary Artery Disease

  • Hypertension

  • Inflammatory Arthritis

Biomarkers

  • Tumor necrosis factor

  • Body mass index

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Abatacept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved